Among these, Juglone, a natural plant compound, has been established to reduce Pin1 protein expression and inhibit the progression of prostate cancer by targeting Pin1 activity (69), whereas by binding non-covalently to the active site of Pin1, arsenic trioxide (ATO) inhibits and degrades Pin1, thereby suppressing its oncogenic function. The gene discussed is PIN1; the disease is prostate carcinoma.